Clinical Outcome with Standard Regimen plus Clofazimine or Moxifloxacin in Cavitary Mycobacterium avium Complex Pulmonary Disease

被引：3
|
作者：
Park, Yea Eun [1 ]
Chong, Yong Pil [2 ]
Lee, Hyun Joo [3 ]
Shim, Tae Sun [1 ]
Jo, Kyung-Wook [1 ]
机构：
[1] Univ Ulsan, Div Pulmonol & Crit Care Med, Dept Internal Med, Asan Med Ctr,Coll Med, Seoul, South Korea
[2] Univ Ulsan, Asan Med Ctr, Dept Infect Dis, Coll Med, Seoul, South Korea
[3] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2022年 / 66卷 / 12期
基金：
新加坡国家研究基金会;
关键词：
cavitary MAC-PD; clofazimine; moxifloxacin;
D O I：
10.1128/aac.00528-22
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
In this retrospective analysis including 173 patients in a tertiary referral center in South Korea, compared with the standard therapeutic regimen, clofazimine or moxifloxacin plus standard treatment regimen potentially did not induce a higher 1-year culture conversion rate in patients with Mycobacterium avium complex pulmonary disease who present with cavitary lesions (fibrocavitary or cavitary nodular bronchiectatic type).
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Effectiveness of clofazimine-containing regimen in the treatment of Mycobacterium avium complex pulmonary disease
    Lee, Inhan
    Kwak, Nakwon
    RESPIROLOGY, 2023, 28 : 113 - 113
  • [2] Treatment of severe Mycobacterium avium complex pulmonary disease with adjunctive amikacin and clofazimine versus standard regimen alone: a retrospective study
    Zweijpfenning, Sanne M. H.
    Kops, Stephan E. P.
    Boeree, Martin J.
    Kuipers, Saskia
    van Ingen, Jakko
    Hoefsloot, Wouter
    Magis-Escurra, Cecile
    ERJ OPEN RESEARCH, 2021, 7 (04)
  • [3] Treatment of severe Mycobacterium avium complex pulmonary disease with a adjunctive amikacin and clofazimine versus standard regimen alone, a retrospective study
    Zweijpfenning, Sanne
    Kops, Stephan
    Boeree, Martin
    Kuipers, Saskia
    Van Ingen, Jakko
    Hoefsloot, Wouter
    Magis-Escurra, Cecile
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease
    Okumura, Masao
    Iwai, Kazuro
    Ogata, Hideo
    Ueyama, Masako
    Kubota, Motoko
    Aoki, Misako
    Kokuto, Hiroyuki
    Tadokoro, Eiji
    Uchiyama, Takashi
    Saotome, Mikio
    Yoshiyama, Takashi
    Yoshimori, Kouzou
    Yoshida, Naoyuki
    Azuma, Arata
    Kudoh, Shoji
    INTERNAL MEDICINE, 2008, 47 (16) : 1465 - 1472
  • [5] Efficacy of clofazimine-containing regimens for treatment of Mycobacterium avium complex-pulmonary disease in patients unsuitable for standard treatment regimen
    Bao, Shengjuan
    Chen, Suting
    Zheng, Jifang
    Ma, Junke
    Yang, Jiali
    Huang, Hairong
    Duan, Hongfei
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (02)
  • [6] A COMPARISON OF A FLUOROQUINOLONE-CONTAINING REGIMEN AND STANDARD REGIMEN IN TREATMENTS FOR PULMONARY MYCOBACTERIUM AVIUM COMPLEX DISEASE
    Shuto, Hisayuki
    Komiya, Kosaku
    Takikawa, Shuichi
    Yoshimatsu, Tetsuyuki
    Otsu, Tastuya
    Kawano, Hiroshi
    Kadota, Jun-Ichi
    RESPIROLOGY, 2019, 24 : 129 - 129
  • [7] Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease
    Tanaka, E
    Kimoto, T
    Tsuyuguchi, K
    Watanabe, I
    Matsumoto, H
    Niimi, A
    Suzuki, K
    Murayama, T
    Amitani, R
    Kuze, F
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) : 866 - 872
  • [8] Treatment of refractory mycobacterium avium complex lung disease with a moxifloxacin-containing regimen
    Hong, Goohyeon
    Kim, Su-Young
    Jeong, Byeong-Ho
    Park, Hye Yun
    Jeon, Kyeongman
    Kwon, O. Jung
    Lee, Seung-Heon
    Kim, Chang Ki
    Shin, Sung Jae
    Koh, Won-Jung
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [9] Treatment of Refractory Mycobacterium avium Complex Lung Disease with a Moxifloxacin-Containing Regimen
    Koh, Won-Jung
    Hong, Goohyeon
    Kim, Su-Young
    Jeong, Byeong-Ho
    Park, Hye Yun
    Jeon, Kyeongman
    Kwon, O. Jung
    Lee, Seung-Heon
    Kim, Chang Ki
    Shin, Sung Jae
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (05) : 2281 - 2285
  • [10] A 'shock and awe' thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium-intracellulare complex disease
    Srivastava, Shashikant
    Deshpande, Devyani
    Sherman, Carleton M.
    Gumbo, Tawanda
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 : 43 - 47
12345